FDLI Conference In Brief
This article was originally published in The Tan Sheet
Law professor dubs Zicam AER case one to watch in 2012; Cargill draws legal line between customers’ food and supplement products.
You may also be interested in...
CHPA stands up for gluten in OTCs; Sen. Durbin targets energy drink supplement labeling; CDC report delves into U.S. nutritional data; P&G files tooth whitening patent suit against Be Well Health Marketing; more news In Brief.
The Supreme Court's decision in the lawsuit alleging Matrixx Initiatives fraudulently withheld adverse event reports from investors provides little guidance for pharmaceutical and dietary supplement firms on disclosing adverse events, an expert says.
Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.